Concepedia

Rahul Lakhotia

RL

Statistics

Publications

11

Citations

245

H-Index

10

Active since

2018

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

National Institutes of Health

Adaptive Biotechnologies (United States)

National Institutes of Health Clinical Center

Rahul Lakhotia is an author at National Cancer Institute specializing in medicine, oncology, and molecular oncology.

Publications per year

2018–2024

11

Publications

11

Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma

Christopher Melani, Rahul Lakhotia, Stefania Pittaluga et al. · New England Journal of Medicine · 2024 · 65 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma

Rahul Lakhotia, Christopher Melani, Kieron Dunleavy et al. · Blood Advances · 2022 · 44 citations · Full text

Medicine, Hematology, Oncology +17

Natural history of benign ethnic neutropenia in individuals of African ancestry

Rahul Lakhotia, Anita Aggarwal, Mary E. Link et al. · Blood Cells Molecules and Diseases · 2019 · 22 citations · Full text

Medicine, Hematology, Pathobiology +4

Next-Generation Sequencing-Based Monitoring of Circulating Tumor DNA Reveals Clonotypic Heterogeneity in Untreated PTCL

Miloš D. Miljković, Christopher Melani, Stefania Pittaluga et al. · Blood Advances · 2021 · 22 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Phase 1b/2 Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Analysis

Christopher Melani, Rahul Lakhotia, Stefania Pittaluga et al. · Blood · 2020 · 17 citations

Medicine, Hematology, Pharmacology +16

1–5 of 11